(Q61270971)
Statements
Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA (English)
Atle Bjornerod
Marga Spiller
Kenneth E Kellar
Dennis K Fujii
Wolfgang H H Gunther
Karen Briley-Saebø
Seymour H Koenig
1
0 references